Cargando...

Surface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirin

BACKGROUND AND PURPOSE: Clinical studies demonstrate that aspirin consumption reverses the gastrointestinal (GI) benefits of coxibs, by an undefined mechanism. EXPERIMENTAL APPROACH: Rodent models were employed to investigate the effects of combinations of celecoxib and aspirin on gastric ulcerogene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lichtenberger, L M, Romero, J J, Dial, E J
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2007
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2013889/
https://ncbi.nlm.nih.gov/pubmed/17325651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707176
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!